Cite
MLA Citation
Paul G. Richardson et al.. “Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.” Journal of clinical oncology, vol. 39, no. 22, 2021, pp. 2430–2442. http://access.bl.uk/ark:/81055/vdc_100150610964.0x000029